HIGHLIGHTS
- who: Rebecca Haydock from the Infirmary, Great George Street, Leeds , EX, UK Building, University of Nottingham, University Park, Nottingham have published the paper: The DEVA trial: protocol for a randomised controlled trial of dequalinium chloride versus usual care antibiotics for the treatment of bacterial vaginosis, in the Journal: (JOURNAL) of 20/01/2020
- what: The aim is to determine if the proportion of women reporting resolution of BV symptoms 4 weeks after treatment is not worse in women treated with dequalinium chloride compared to usual care antibiotics, without the need for additional treatment.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.